melissa suzanne cline american biologist associate research scientist uc santa cruz genomics institute june december staff scientist affymetrix inc emeryville california involved developing anosva statistical method identify alternative spicing expression data analyzed effects alternative splicing protein transmembrane signal peptide subsequently moved uc santa cruz wrote genome according thomson reuters report one highly cited scientists world cline currently program manager brca exchange platform shares knowledge tens thousands brca brca genetic variants could influence persons susceptibility breast cancer particularly clinical significance one challenge curating clinical impact genetic variants curation often relies clinical evidence variants patients families protect patient privacy genetic data siloed maintained closed databases data inaccessible addressing problem dr cline colleagues devised federated analysis approach analyze patient data within secure home repository gathering new knowledge variant curation safeguarding patient approach successfully gathered new variant knowledge siloed data advancing curation brca article biologist united states stub help wikipedia expanding httpsenwikipediaorgwikimelissascline